Abacavir
Back to searchMolecule Structure
Scientific Name
Abacavir
Description of the Drug
Abacavir is an antiviral nucleoside reverse transcriptase inhibitor used in combination with other antiretrovirals for the treatment of HIV.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01048
http://www.drugbank.ca/drugs/DB01048
Brand Name(s)
Ziagen
Company Owner(s)
Cipla Ltd, Apotex Inc, Laurus Labs Ltd, Viiv Healthcare Co, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc, Teva Pharmaceuticals Usa, Strides Pharma Global Pte Ltd, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL38632 | |||
| PharmGKB | PA448004 | |||
| Human Metabolome Database | HMDB0015182 | |||
| DrugBank | DB01048 | |||
| PubChem: Thomson Pharma | 14775540 | 14799909 | ||
| PubChem | 441300 | |||
| LINCS | LSM-43340 | |||
| Nikkaji | J825.172J | |||
| PDBe | 1KX | |||
| BindingDB | 50366816 | |||
| DrugCentral | 34 | |||
| ChemicalBook | CB5698138 | |||
| Guide to Pharmacology | 11152 | |||
| rxnorm | ZIAGEN | ABACAVIR SULFATE | EPZICOM | ABACAVIR |
| KEGG Ligand | C07624 | |||
| ChEBI | 421707 | |||
| ZINC | ZINC000002015928 |
